1 – 15 of 61
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Cumulative Absolute Risk of Subsequent Colorectal Cancer After Abdominopelvic Radiotherapy Among Childhood Cancer Survivors : A PanCareSurFup Study
(
- Contribution to journal › Article
- 2023
-
Mark
Clonal Hematopoiesis and Risk of Incident Lung Cancer
2023) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41(7). p.1423-1433(
- Contribution to journal › Article
-
Mark
Risk Factors for Heart Failure among Pan-European Childhood Cancer Survivors : A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study
(
- Contribution to journal › Article
-
Mark
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma with Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination
(
- Contribution to journal › Article
-
Mark
Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer
(
- Contribution to journal › Article
-
Mark
Chromosomal Gains as a Favorable Prognostic Factor in Pediatric ALL
(
- Contribution to journal › Article
-
Mark
Reply to V. Nardone et al
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Risk Factors for Primary Bone Cancer After Childhood Cancer : A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study
2023) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41(21). p.3735-3746(
- Contribution to journal › Article
-
Mark
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
2023) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41(10). p.1849-1863(
- Contribution to journal › Article
- 2022
-
Mark
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
(
- Contribution to journal › Article
-
Mark
Selumetinib Plus Adjuvant Radioactive Iodine in Patients with High-Risk Differentiated Thyroid Cancer : A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)
(
- Contribution to journal › Article
- 2021
-
Mark
Low-Dose Tamoxifen for Mammographic Density Reduction : A Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
Burkitt Lymphoma International Prognostic Index
2021) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39(10). p.1129-1138(
- Contribution to journal › Article
-
Mark
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer : Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study
2021) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39(20). p.2294-2303(
- Contribution to journal › Article
-
Mark
ARTSCAN III : A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer
(
- Contribution to journal › Article